Published in Eur Neurol on January 01, 1988
Alpha 1-antichymotrypsin is present in diffuse senile plaques. A comparative study of beta-protein and alpha 1-antichymotrypsin immunostaining in the Alzheimer brain. Am J Pathol (1991) 0.97
Systemic immune system alterations in early stages of Alzheimer's disease. J Neuroimmunol (2013) 0.94
CCAAT-enhancer binding protein-β expression and elevation in Alzheimer's disease and microglial cell cultures. PLoS One (2014) 0.80
Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS). Oncotarget (2015) 0.80
Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study. J Alzheimers Dis (2012) 0.75
Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects. Neurobiol Aging (2013) 0.75
Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol (2001) 1.90
Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J Neuroimmunol (1989) 1.59
Detection of paraneoplastic anti-neuronal autoantibodies on paraffin-embedded tissues. Acta Neuropathol (1996) 1.39
Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. Blood (1999) 1.36
Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group. AIDS (1997) 1.30
Core antigen-specific immunoglobulin G bound to the liver cell membrane in chronic hepatitis B. Gastroenterology (1982) 1.24
Suppressor cell activity in viral and non-viral chronic active hepatitis. Clin Exp Immunol (1980) 1.23
Glutamic acid decarboxylase autoantibodies and neurological disorders. Neurol Sci (2002) 1.15
Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities. Ann Neurol (1997) 1.09
Hyper-IGD syndrome: a new case treated with colchicine. Clin Rheumatol (1988) 1.08
Axonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDS. J Neuropathol Exp Neurol (1997) 1.06
Cerebrospinal fluid electroimmunodiffusion. An easy, rapid, sensitive, reliable, and valid method for the simultaneous determination of immunoglobulin-G and albumin. Arch Neurol (1971) 1.03
Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid. J Neurol Sci (1989) 1.02
Rheological and fibrinolytic findings in multiple sclerosis. J Neurol Neurosurg Psychiatry (1981) 1.00
Immune infiltrates and cytokines in gliomas. Acta Neurochir (Wien) (1996) 0.98
Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system. Neuropathol Appl Neurobiol (1997) 0.95
Epidemiological survey on multiple sclerosis in Italy. Riv Patol Nerv Ment (1976) 0.95
The spectrum of antineuronal autoantibodies in a series of neurological patients. J Neurol Sci (2004) 0.93
Prospective study of posttransfusion hepatitis in cardiac surgery patients receiving only blood or also blood products. Vox Sang (1983) 0.91
Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system. J Neurol Sci (1994) 0.90
A single institution's experience (1982-1999) with plasma-exchange therapy in patients with fulminant hepatic failure. Int J Artif Organs (2000) 0.90
Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies. Lancet (1998) 0.90
Macrophage-colony stimulating factor (M-CSF) in the cerebrospinal fluid. J Neuroimmunol (1990) 0.89
Transferrin receptors in rat central nervous system. An immunocytochemical study. J Neurol Sci (1990) 0.89
Programmed cell death in brains of HIV-1-positive AIDS and pre-AIDS patients. Acta Neuropathol (1996) 0.88
Interleukin-2 levels in serum and cerebrospinal fluid of multiple sclerosis patients. Ann Neurol (1988) 0.88
Tumor necrosis factor alpha (TNF alpha) and neurological diseases. Failure in detecting TNF alpha in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumours. J Neuroimmunol (1989) 0.87
Free light chains in the CSF in multiple sclerosis. J Neurol (1987) 0.87
Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies. Cerebellum (2003) 0.86
DHPLC analysis of the MECP2 gene in Italian Rett patients. Hum Mutat (2001) 0.85
Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase antibodies. Eur J Neurol (2005) 0.85
Detection by immunofluorescence of an antigen-antibody system in patients with acute and chronic non-A, non-B hepatitis. Liver (1981) 0.84
X-linked adrenoleukodystrophy with olivopontocerebellar atrophy. Eur J Neurol (2005) 0.83
Characterization of hyperlipidemia in two patients with analbuminemia. Clin Chim Acta (1983) 0.83
Central nervous system involvement in HIV infection. AIDS Res Hum Retroviruses (1988) 0.82
[Infection due to hepatitis B virus and host immune response]. Boll Ist Sieroter Milan (1976) 0.81
Alzheimer's disease and senile brains: an immunofluorescence study. Riv Patol Nerv Ment (1984) 0.81
On the role of interleukin-2 (IL-2) in multiple sclerosis (MS). IL-2-mediated endothelial cell activation. Ital J Neurol Sci (1992) 0.81
Anti-hepatitis C virus serology in patients affected with congenital coagulation defects: a comparative study using three second generation ELISA tests. Transfus Sci (1994) 0.80
Cytokine pattern in the cerebrospinal fluid from patients with GBS and CIDP. J Neurol Sci (1997) 0.80
A longitudinal study on IL-2, sIL-2R, IL-4 and IFN-gamma in multiple sclerosis CSF and serum. J Neurol Sci (1991) 0.79
Therapy of acute pancreatitis in systemic lupus erythematosus with plasmapheresis and corticosteroids. Clin Exp Rheumatol (1985) 0.79
Immunoglobulin light chain patterns in the cerebrospinal fluid. A study with special reference to the occurrence of free light chains in cerebrospinal fluid with and without oligoclonal immunoglobulin G. J Neurol Sci (1989) 0.79
Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine in the treatment of episodic tension-type headache: a double-blind, randomized, nimesulide-controlled, parallel group, multicentre trial. Eur J Neurol (2005) 0.79
Anti-gabaergic neuron autoantibodies in a patient with stiff-man syndrome and ataxia. J Neurol Sci (1996) 0.78
The IgD in the cerebrospinal fluid. Acta Neurol Scand (1968) 0.78
Cerebrospinal fluid analysis in HIV-1-infected children: immunological and virological findings before and after AZT therapy. Acta Paediatr (1994) 0.78
A multicentric seroepidemiological survey of HTLV-I/II in Italy. Clin Diagn Virol (1994) 0.78
Bickerstaff's brainstem encephalitis: case report and Tc99m brain SPECT findings. Neurol Sci (2011) 0.78
Cerebrospinal fluid lymphocytes from HIV-infected patients synthesize HIV-specific antibody in vitro. J Neuroimmunol (1988) 0.78
Effect of high-dose steroid therapy on T-cell subpopulations. A longitudinal study in MS patients. Acta Neurol Scand (1994) 0.78
Toxoplasma encephalitis in the adult. Acta Neurol (Napoli) (1978) 0.77
Study of the IgG oligoclonal bands in cerebral spinal fluid in multiple sclerosis by electroimmunofixation. Ital J Neurol Sci (1982) 0.77
Experimental allergic encephalomyelitis in the monkey: humoral immunity and blood-brain barrier function. Ital J Neurol Sci (1989) 0.77
Immunological markers in the cerebrospinal fluid of HIV-1-infected children. Acta Paediatr Scand (1991) 0.77
Protection from experimental autoimmune encephalomyelitis (EAE): non-depleting anti-CD4 mAb treatment induces peripheral T-cell tolerance to MBP in PL/J mice. J Neuroimmunol (1997) 0.77
Gait analysis and clinical correlations in early Parkinson's disease. Funct Neurol (2017) 0.77
Free light chains of immunoglobulins in the cerebrospinal fluid of human immunodeficiency virus type 1-infected patients. J Neuroimmunol (1990) 0.76
Macrophage-derived cytokines in the cerebrospinal fluid of HIV-1-infected patients. Acta Neurol (Napoli) (1990) 0.76
Fluctuation of serum complement levels in children with neuroblastoma. Cancer (1979) 0.76
Tremor of the mouth floor and anti-glutamic acid decarboxylase autoantibodies. Eur J Neurol (2003) 0.76
Search for HTLV-I and LAV/HTLV-III antibodies in serum and CSF of multiple sclerosis patients. Acta Neurol Scand (1986) 0.76
Immunotherapy-reversed compulsive, monoaminergic, circadian rhythm disorder in Morvan syndrome. Neurology (2008) 0.76
M-CSF production by HIV-1-infected monocytes and its intrathecal synthesis. Implications for neurological HIV-1-related disease. J Neuroimmunol (1994) 0.76
Blood-brain barrier damage restricts the reliability of quantitative formulae and isoelectric focusing in detecting intrathecally synthesized IgG. J Neurol Sci (1988) 0.76
Intrathecal synthesis of anti-HIV oligoclonal IgG in HIV-seropositive patients having no signs of HIV-induced neurologic diseases. Ann N Y Acad Sci (1988) 0.76
LDL-apheresis with the HELP system: a 16-month study in severe hypercholesterolemic patients with ischemic heart disease. Beitr Infusionsther (1988) 0.75
Immunological indices in presenile Alzheimer's disease. J Neurol Sci (1980) 0.75
ALS and paraproteinemia. Neurology (1991) 0.75
[Therapeutic effects of trazodone in the treatment of tremor. Multicentric double-blind study]. Riv Neurol (1987) 0.75
Effect of lymphocytapheresis plus cyclophosphamide on the course of a chronic progressive form of multiple sclerosis. Ital J Neurol Sci (1985) 0.75
Genetic study of red cell esterase D polymorphism by ultrathin layer isoelectric focusing. Distribution in the Veneto population (Italy). Z Rechtsmed (1987) 0.75
Lead polyneuropathy of nonindustrial origin. Eur Neurol (1980) 0.75
[Immunoglobulin G in cerebrospinal fluid of patients with multiple sclerosis. Study with immunosuppression. Preliminary report]. Acta Neurol (Napoli) (1972) 0.75
[T and B lymphocytes in multiple sclerosis]. Acta Neurol (Napoli) (1977) 0.75
[Abnormalities of the immunoglobulin G (IgG) precipitate in the cerebrospinal fluid]. Acta Neurol (Napoli) (1970) 0.75
[Multiple sclerosis: the immunoglobulins of the central nervous system]. Riv Patol Nerv Ment (1974) 0.75
[Immunochemical determination of immunoglobulin G (IgG) in the cerebrospinal fluid]. Riv Sper Freniatr Med Leg Alien Ment (1969) 0.75
Fluorescent cell tracing in multiple sclerosis brain tissue. Trans Am Neurol Assoc (1971) 0.75
Search for specific anti-MS IgG antibodies. Ital J Neurol Sci (1981) 0.75
[Immunological study of a case of subacute sclerosing panencephalitis]. Acta Neurol (Napoli) (1970) 0.75
[Anatomo-clinical study of 4 cases of Jakob-Creutzfeldt disease (spongiform encephalopathy)]. Riv Neurol (1981) 0.75
[Gastric ulcer, duodenal ulcer and major and minor blood groups. Epidemiological aspects, functional correlations, clinical implications]. Minerva Dietol Gastroenterol (1987) 0.75
[2 cases of atypical encephalitis]. Acta Neurol (Napoli) (1976) 0.75
M.S. diagnostic test: a comparison of different electrophoretic and immunologic methods for CFS IgG estimation. Boll Ist Sieroter Milan (1978) 0.75
[Not Available]. Acta Med Hist Patav (1976) 0.75
[Amyotrophic lateral sclerosis: immunological study]. Acta Neurol (Napoli) (1976) 0.75
[Down syndrome: immunological study in adults (author's transl)]. Riv Patol Nerv Ment (1979) 0.75
[Anatomo-clinical observations on 2 cases of cerebral aspergillosis]. Acta Neurol (Napoli) (1970) 0.75